Inventor · disambiguated record
Robert B. Innis
Also filed as: INNIS ROBERT · INNIS ROBERT B
6 granted patents·5 pending applications·149 citations·filing 1992–2019
84Inventor score
Files withRES BIOCHEMICALS LIMITED PARTN2AMERSHAM PLC1CAI LISHENG1NAT INST OF HEALTH REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES NAT INST OF1NEURO IMAGING TECHNOLOGIES LLC1
Top patents by PatentIndex Score
11 records- 0191US5310912AIodinated neuroprobe for mapping monoamine reuptake sitesRES BIOCHEMICALS LIMITED PARTN·Filed 1992·Granted May 10, 1994·64 cites·8 claims
- 0289US5439666AIodinated neuroprobe for mapping monoamine reuptake sitesRES BIOCHEMICALS LIMITED PARTN·Filed 1994·Granted Aug 8, 1995·47 cites·6 claims
- 0379US5698179AIodinated neuroprobe for mapping monoamine reuptake sitesNEURO IMAGING TECHNOLOGIES LLC·Filed 1995·Granted Dec 16, 1997·28 cites·11 claims
- 0464US8703096B2Beta-amyloid PET imaging agentsCAI LISHENG·Filed 2007·Granted Apr 22, 2014·3 cites·12 claims
- 0550US2014341812A1Beta-amyloid pet imaging agentsUS HEALTH·Filed 2014·Application pending·0 cites
- 0648US7989630B2Radiotracers for imaging P-glycoprotein functionNAT INST OF HEALTH REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES NAT INST OF·Filed 2008·Granted Aug 2, 2011·1 cites·2 claims
- 0743US2003130336A1Method of determining the activity of a central nervous system drug on striatal dopamine transporter populationsPFIZER·Filed 2002·Application pending·0 cites
- 0842US6537522B1Neuroprobes for mapping monoamine reuptake sitesAMERSHAM PLC·Filed 1998·Granted Mar 25, 2003·6 cites·3 claims
- 0939US2021094920A1Nr2b ligands; method of making; and use thereofTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
- 1033US2003013883A1Tropane analogs binding to monoamine transportersFiled 2001·Application pending·0 cites
- 1130US2002111486A1Transition metal-cyclopentadienyl-tropane conjugatesFiled 2000·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →